Picard Medical, Inc. (PMI) research
Picard Medical, Inc.- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $5.78
- As of
Picard Medical, Inc. (PMI): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-20.
As of . Source: SEC EDGAR filings for PMI. Method and limitations.
Share the PMI intelligence card
See the full PMI dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for PMI on one page. Preview it with sample data, then open it live with a free account.
Preview the PMI dossierActive signals for PMI
- mediumNEW_POSITION
RENAISSANCE TECHNOLOGIES LLC new position in PMI
FREE, NO ACCOUNT
Every signal on PMI, as it fires
New filings, 13F moves and cross asset signals on PMI land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in PMI (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 71953R108 · 2026Q2 | $28K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, PMI
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Kresmion Research Notes on PMI
PMI mentioned in Kresmion daily briefs
PMI against its peers
PMI's operating margin of -268.4% ranks in the 66th percentile of 15 Medical Devices sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | PMI | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 4.9M USD | 1.4M USD | 78 | 19 |
| Revenue YoY | n/a | -5.9% | n/a | 6 |
| Gross margin | -4.1% | 45.3% | 8 | 17 |
| Operating margin | -268.4% | -446.7% | 66 | 15 |
| Net margin | -546.6% | -431.1% | 45 | 18 |
| Return on equity | -712.6% | -175.5% | 9 | 16 |
Peers (21): IRIX, BMRA, ALRTF, CTSO, TANAF, SINT, WOK, PLSM, CODX, ICCM, AMIX, MODD, VNRX, GTHP, NVNO, LFWD, INBS, HSCS, AIDX, RDGL, ITOC. Left out: NMTC (no annual filing), SONX (period gap), KLYG (no annual filing), TRIB (period gap). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (PMI: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more PMI signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to PMIand get the insider, 13F, options, and confluence read in one view.